6549TaiwanJ Pharmaceuticals6549 info
$0.32info-0.49%24h
Global rank29137
Market cap$24.08M
Change 7d-1.91%
YTD Performance-30.74%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    TaiwanJ Pharmaceuticals (6549) Stock Overview

    TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2011 and is based in Zhubei, Taiwan.

    6549 Stock Information

    Symbol
    6549
    Address
    No.2 ShengYi RoadZhubei, 302058Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://www.taiwanj.com
    Country
    🇹🇼 Taiwan
    Phone Number
    886 3 658 7721

    TaiwanJ Pharmaceuticals (6549) Price Chart

    -
    Value:-

    TaiwanJ Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.3204817544265565
    N/A
    Market Cap
    $24.08M
    N/A
    Shares Outstanding
    75.12M
    N/A
    Employees
    11.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org